How do you interpret noncash income (loss) from equity method investments?

Positive values indicate the investee is profitable; negative values indicate the investee is incurring losses.

How does noncash income (loss) from equity method investments compare across companies?

Common for companies with strategic partnerships or joint ventures in the biotech sector.

BridgeBio Pharma BBIO Noncash Income (Loss) from Equity Method Investments

Discontinued — last reported Q4 '25

Noncash Income (Loss) from Equity Method Investments at other companies

StarbucksSBUX

$65.7M+5.3%

Hewlett Packard EnterpriseHPE

$22.5M-38.8%

Church & DwightCHD

$1.98M-13.2%

Church & DwightCHD

$2.7M+17.4%

PopularBPOP

——

Blackstone Mortgage TrustBXMT

——

Other financials

Income statement

See full

Revenue$194.5M+66.8%

Gross profit$184.6M+61.9%

Operating income-$106.0M-1.5%

Net income-$166.6M+1.8%

EPS (diluted)-$0.84+4.5%

Balance sheet

See full

Cash & equivalents$882.0M+62.5%

Total debt$3.3B+32,101%

Total equity-$2.3B-38.2%

Total assets$1.4B+55.5%

Cash flow

See full

Operating cash flow-$197.3M+1.0%

CapEx$69.0K—

Free cash flow-$197.3M+0.9%

Valuation

See full

Market cap$12.98B+119%

Enterprise value$15.36B+178%

P/S22.4×-24.1×

Profitability

See full

Gross margin95.1%-0.2pp

Operating margin-90.5%-41.2pp

Net margin-125.9%-54.5pp

FCF margin-76.8%—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity2×—

Current ratio1.5×-3.0×

Where this comes from

Reported directly by BridgeBio Pharma in its filing.

Tagged under the XBRL concept bbio:NoncashIncomeLossFromEquityMethodInvestments.

The official record: BridgeBio Pharma’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about BridgeBio Pharma's noncash income (loss) from equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BridgeBio Pharma's noncash income (loss) from equity method investments?: BridgeBio Pharma (BBIO) reported noncash income (loss) from equity method investments of $1.06M in Q4 2025.
What does noncash income (loss) from equity method investments mean?: The company's share of profits or losses from businesses it partially owns.
How do you interpret noncash income (loss) from equity method investments?: Positive values indicate the investee is profitable; negative values indicate the investee is incurring losses.
How does noncash income (loss) from equity method investments compare across companies?: Common for companies with strategic partnerships or joint ventures in the biotech sector.